Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space ...

GSK is the fifth company to leave BIO in roughly a year, a group that includes Pfizer and UCB. The departures coincided with ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

The company ended the quarter with $192 million in cash and equivalents, enough to fund operations past 2027. 2seventy Bio ...

MEMS, wearable/implantable electronics and bio-tissue therapeutics, the pursuit of piezoelectric biomaterials has become a ...

FDA 510(k) Clearance Would Enable the Introduction of INBS’ Technology to the US in 2025 NEW YORK, Nov. 13, ...

MORE: Jake Paul has released the beast in Mike Tyson. Who is Jake Paul's girlfriend Jutta Leerdam? Turning pro in 2018, ...

Ariel Investments, an investment management company, released its “Ariel Focus Fund” third-quarter 2024 investor letter. A ...

Binance Labs has invested in BIO Protocol, a pioneering protocol transforming the way early-stage scientific research is ...

Bio-based materials may pose a greater health risk to some of the planet's most important species than the conventional ...

bluebird bio BLUE is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement. Analysts estimate that bluebird bio will ...

Kronos Bio, Inc. (KRON) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.54 per share a year ago. These figures are ...